Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Flaherty

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseasesColin Holtze, Kevin Flaherty, Michael Kreuter, et al.
Advances in Therapy|July 5, 2022
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILDMartin Kolb, Stylianos E Orfanos, Chris Lambers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2019
Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic SclerosisAmber Young, Dharshan Vummidi, Scott Visovatti, et al.
Cornea|September 12, 2012
Individual phenotypic variances in a family with Thiel-Behnke corneal dystrophyHisashi Nakamura, Frank T Li, Miles O Foltermann, et al.
Lung|June 18, 2017
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET TrialJonathan A Galli, Nicholas L Panetta, Nathaniel Gaeckle, et al.
Rheumatology (Oxford, England)|November 15, 2022
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohortAhmad Ramahi, Alain Lescoat, David Roofeh, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung diseaseCaitlyn J Fisher, Rajaie Namas, Daniela Seelman, et al.
The Journal of Rheumatology|March 3, 2015
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working GroupDinesh Khanna, Shikha Mittoo, Rohit Aggarwal, et al.
Respiratory Medicine|December 29, 2009
Gender influences Health-Related Quality of Life in IPFMeiLan K Han, Jeffrey Swigris, Lyrica Liu, et al.
American Journal of Respiratory and Critical Care Medicine|January 18, 2024
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation RegistryChristopher S King, Rosalinda V Ignacio, Vikramjit Khangoora, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseasesColin Holtze, Kevin Flaherty, Michael Kreuter, et al.
Advances in Therapy|July 5, 2022
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILDMartin Kolb, Stylianos E Orfanos, Chris Lambers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2019
Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic SclerosisAmber Young, Dharshan Vummidi, Scott Visovatti, et al.
Cornea|September 12, 2012
Individual phenotypic variances in a family with Thiel-Behnke corneal dystrophyHisashi Nakamura, Frank T Li, Miles O Foltermann, et al.
Lung|June 18, 2017
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET TrialJonathan A Galli, Nicholas L Panetta, Nathaniel Gaeckle, et al.
Rheumatology (Oxford, England)|November 15, 2022
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohortAhmad Ramahi, Alain Lescoat, David Roofeh, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung diseaseCaitlyn J Fisher, Rajaie Namas, Daniela Seelman, et al.
The Journal of Rheumatology|March 3, 2015
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working GroupDinesh Khanna, Shikha Mittoo, Rohit Aggarwal, et al.
Respiratory Medicine|December 29, 2009
Gender influences Health-Related Quality of Life in IPFMeiLan K Han, Jeffrey Swigris, Lyrica Liu, et al.
American Journal of Respiratory and Critical Care Medicine|January 18, 2024
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation RegistryChristopher S King, Rosalinda V Ignacio, Vikramjit Khangoora, et al.
Pageof 4